 WATERTOWN, Mass., July 12, 2021 GLOBE NEWSWIRE -- Lyra Therapeutics, Inc. Nasdaq: LYRA, a clinical-stage therapeutics company leveraging its proprietary XTreoTM platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat ENT passages and other diseased tissues, today announced that Maria Palasis, Ph.D., Lyras President and Chief Executive Officer, will present at the William Blair Biotech Focus Conference on Thursday, July 15, 2021 at 10:00 a.m. ET. A live webcast of the fireside chat presentation will be available in the Investor Relations section of the Companys website at The webcast replay will be available for 30 days following the event. 